[Department Memorandum No. 2021- 0158] Inclusion of 0.1% Sodium Hyaluronate (15 ml) and 2.5% Peritoneal Dialysis Solution (2L and 5L) in the Philippine National Formulary Posted on April 5, 2021
[Department Circular No. 2021- 0079] Health Technology Assessment Council’s (HTAC) Recommendations on health technologies requiring Full Certificate of Registration (CPR) from the Food and Drug Administration Posted on March 5, 2021
[Department Memorandum No. 2021- 0075] Compliance to Dissemination of the Recommendations of the Health Technology Assessment Council (HTAC) Posted on February 26, 2021
[Department Memorandum No. 2021- 0097] Health Technology Assessment Council’s (HTAC) Recommendations on COVID-19 Health Technologies Posted on February 26, 2021
[Memo to DOH Internal Offices] Acknowledgement of Comments_Concurrence on COVID-19 Vaccines Evaluation Framework Posted on February 15, 2021
